Aspirin enhances cisplatin sensitivity of resistant non-small cell lung carcinoma stem-like cells by targeting mTOR-Akt axis to repress migration. [electronic resource]
Producer: 20201106Description: 16913 p. digitalISSN:- 2045-2322
- Antineoplastic Agents -- pharmacology
- Aspirin -- pharmacology
- Carcinoma, Non-Small-Cell Lung
- Cell Line, Tumor
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Cisplatin -- pharmacology
- Drug Resistance, Neoplasm -- drug effects
- Drug Synergism
- Epithelial-Mesenchymal Transition -- drug effects
- Humans
- Lung Neoplasms
- Neoplastic Stem Cells -- drug effects
- Proto-Oncogene Proteins c-akt -- metabolism
- Signal Transduction -- drug effects
- TOR Serine-Threonine Kinases -- metabolism
- Transcription Factor RelA -- metabolism
- p300-CBP Transcription Factors -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.